TABLE 1

Psilocin and 4-hydroxyindole glucuronidation kinetics

The values represent a best-fit result ± S.E. The reaction velocity is presented both as actual rates and rates normalized to UGT1A10 expression level (i.e., for UGT1A10, the actual and normalized rates are identical). See Materials and Methods for additional details.

SubstrateEnzymeKmVmax (Actual Rates)Vmax (Normalized Rates)KisKinetic Model (r2)
μMnmol/min/mgnmol/min/mgμM
PsilocinUGT1A103851.0 ± 166.62.53 ± 0.06Michaelis-Menten (0.997)
UGT1A9Km1 = 1017.0 ± 249.9aVmax1 = 0.38 ± 0.14aVmax1 = 0.19 ± 0.04aTwo-site biphasic (0.996)
4OH-IndoleUGT1A103624.0 ± 839.7b3.36 ± 0.63b2603.0 ± 744.8Substrate inhibition (0.992)
UGT1A6178.7 ± 14.89.31 ± 0.454.78 ± 0.23765.1 ± 65.5Substrate inhibition (0.991)
UGT2A13210.0 ± 235.71.48 ± 0.060.39 ± 0.02Michaelis-Menten (0.992)
  • a The calculated CLint is 1.69 × 10−4 ± 1.04 × 10−5 ml/min/mg (normalized, 8.29 × 10−5 ± 5.12 × 10−6 ml/min/mg) and represents the linear portion of the biphasic curve (ratio Vmax2/Km2). Data were also fitted to the Michaelis-Menten equation, Km = 12047 ± 1428 μM, Vmax = 3.41 ± 0.31 (normalized, 1.66 ± 0.15) nmol/min/mg, r2 = 0.996.

  • b Data were also fitted to the Hill equation, S50 = 631.6 ± 32.7 μM, Vmax = 1.03 ± 0.02 nmol/min/mg, Hill coefficient h = 1.60 ± 0.11, r2 = 0.986.